Funder
Department of Biotechnology, Government of India
University Grants Commission
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Olijhoek JK, van der Graaf Y, Banga JD, Algra A, Rabelink TJ, Visseren FL. The metabolic syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysm. Eur Heart J. 2004;25(4):342–8. https://doi.org/10.1016/j.ehj.2003.12.007.
2. Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066–72. https://doi.org/10.1161/CIRCULATIONAHA.105.539528.
3. IDF Epidemiology Task Force Consensus Group. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org/webdata/docs/Metabolic_syndrome_def.pdf. 2005. (Accessed September 27, 2019).
4. Brindle P, May M, Gill P, Cappuccio F, D’Agostino R, Fischbacher C, et al. Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups. Heart. 2006;92(11):1595–602. https://doi.org/10.1136/hrt.2006.092346.
5. D'Agostino RB Sr, Pencina MJ, Massaro JM, Coady S. Cardiovascular disease risk assessment: insights from Framingham. Glob Heart. 2013;8(1):11–23. https://doi.org/10.1016/j.gheart.2013.01.001.